Related Experiment Videos
Long-term results after carotid artery surgery
C Forssell1, R Takolander, D Bergqvist
1Department of Surgery, University of Lund, Malmö General Hospital, Sweden.
European Journal of Vascular Surgery
|April 1, 1988
Summary
Carotid reconstructions show good long-term results, with 75.8% survival and 253 asymptomatic patients. Coronary artery disease negatively impacted survival and was more common in bilateral carotid lesions.
Area of Science:
- Vascular Surgery
- Neurology
- Cardiology
Background:
- Carotid artery disease poses a significant risk for stroke.
- Carotid reconstruction aims to prevent stroke and improve patient outcomes.
- Long-term follow-up data is crucial for evaluating the efficacy of carotid reconstruction.
Purpose of the Study:
- To evaluate the long-term outcomes of carotid reconstructions.
- To assess survival rates and asymptomatic status post-procedure.
- To identify factors influencing outcomes, such as coronary artery disease and lesion laterality.
Main Methods:
- A retrospective analysis of 414 carotid reconstructions in 352 patients (1971-1982).
- Follow-up data collected over a median of 35 months (range: 6 months–12 years).
- Analysis included survival rates, asymptomatic status, and stroke frequency, stratified by patient characteristics.
Main Results:
- At follow-up, 75.8% of patients (267) were alive, with 253 remaining asymptomatic.
- Patients with coronary artery disease (CAD) had significantly lower survival rates.
- CAD was more prevalent in patients with bilateral carotid lesions compared to unilateral lesions.
- Actuarial stroke frequency was 2.5%/year including operative morbidity, decreasing to 1%/year from 6 months to 8 years postoperatively.
- No significant difference in stroke rates was observed between age groups.
Conclusions:
- Carotid reconstruction offers favorable long-term survival and asymptomatic outcomes.
- Coronary artery disease is a significant negative prognostic factor in patients undergoing carotid reconstruction.
- The study highlights the importance of considering comorbidities in managing carotid artery disease.